Plasminogen activator inhibitor-1 (PAI-1) could act as a mediator of depression-induced CVDs through sleep disorder, adiposity, BDNF metabolism, systemic inflammation, and hypothalamic-pituitary-adrenal (HPA) axis dysregulation. Here, SERPINE1 is linked to depressive symptom measurement.